HHLR ADVISORS, LTD. - Q2 2021 holdings

$9.71 Billion is the total value of HHLR ADVISORS, LTD.'s 89 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 22.0% .

 Value Shares↓ Weighting
BGNE  BEIGENE LTDsponsored adr$1,878,025,000
-1.4%
5,472,2590.0%19.33%
+2.7%
PDD SellPINDUODUO INCsponsored ads$876,708,000
-35.9%
6,902,129
-32.5%
9.02%
-33.3%
IQ  IQIYI INCsponsored ads$602,143,000
-6.3%
38,648,4770.0%6.20%
-2.4%
IMAB  I MABsponsored ads$555,427,000
+73.2%
6,616,1700.0%5.72%
+80.4%
ESGR  ENSTAR GROUP LIMITED$417,594,000
-3.2%
1,747,8400.0%4.30%
+0.9%
ZM SellZOOM VIDEO COMMUNICATION INcl a$397,635,000
-37.4%
1,027,400
-48.0%
4.09%
-34.8%
BBIO  BRIDGEBIO PHARMA INC$326,868,000
-1.0%
5,362,0140.0%3.36%
+3.1%
ABNB NewAIRBNB INC$323,529,0002,112,637
+100.0%
3.33%
JD SellJD.COM INCspon adr cl a$293,965,000
-16.3%
3,683,307
-11.5%
3.03%
-12.8%
CRM  SALESFORCE COM INC$277,607,000
+15.3%
1,136,4760.0%2.86%
+20.1%
UBER SellUBER TECHNOLOGIES INC$271,661,000
-26.6%
5,420,202
-20.2%
2.80%
-23.6%
BILI  BILIBILI INCspons ads rep z$243,469,000
+13.8%
1,998,2710.0%2.51%
+18.5%
BEKE  KE HLDGS INCsponsored ads$238,977,000
-16.3%
5,012,1000.0%2.46%
-12.8%
BEAM SellBEAM THERAPEUTICS INC$237,567,000
+43.2%
1,845,753
-10.9%
2.44%
+49.2%
DASH BuyDOORDASH INCcl a$213,336,000
+48.4%
1,196,300
+9.1%
2.20%
+54.5%
APLS SellAPELLIS PHARMACEUTICALS INC$185,158,000
-5.3%
2,929,708
-35.7%
1.91%
-1.4%
VIPS BuyVIPSHOP HOLDINGS LIMITEDsponsored ads a$179,992,000
+1182.5%
8,963,752
+1807.2%
1.85%
+1233.1%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$161,785,000
+425.8%
713,400
+425.7%
1.66%
+447.7%
MNSO BuyMINISO GROUP HLDG LTDsponsored ads$117,536,000
+1545.9%
5,653,476
+1801.7%
1.21%
+1604.2%
MDLZ  MONDELEZ INTL INCcl a$116,274,000
+6.7%
1,862,1640.0%1.20%
+11.1%
ARGX SellARGENX SEsponsored adr$107,482,000
+3.9%
357,000
-4.9%
1.11%
+8.2%
FGEN  FIBROGEN INC$105,343,000
-23.3%
3,955,7870.0%1.08%
-20.1%
ZTO  ZTO EXPRESS CAYMAN INCsponsored ads a$78,934,000
+4.1%
2,600,7770.0%0.81%
+8.5%
PLTK  PLAYTIKA HLDG CORP$78,212,000
-12.4%
3,280,6990.0%0.80%
-8.7%
KOD SellKODIAK SCIENCES INC$75,349,000
-25.2%
810,207
-8.8%
0.78%
-22.1%
GOSS  GOSSAMER BIO INC$60,258,000
-12.2%
7,420,9740.0%0.62%
-8.6%
TUYA  TUYA INCsponsered ads$58,188,000
+15.9%
2,375,0000.0%0.60%
+20.8%
BPMC SellBLUEPRINT MEDICINES CORP$55,881,000
-24.2%
635,302
-16.3%
0.58%
-21.1%
AMG  AFFILIATED MANAGERS GROUP IN$51,672,000
+3.5%
335,0730.0%0.53%
+7.9%
OTIS  OTIS WORLDWIDE CORP$50,252,000
+19.5%
614,5560.0%0.52%
+24.3%
TIL  INSTIL BIO INC$46,087,000
-23.0%
2,385,4570.0%0.47%
-19.8%
NIO BuyNIO INCspon ads$45,709,000
+821.9%
859,200
+575.5%
0.47%
+861.2%
ALGS  ALIGOS THERAPEUTICS INC$44,135,000
-10.4%
2,165,0640.0%0.45%
-6.8%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$43,317,000
+1.6%
360,4950.0%0.45%
+5.9%
DIDI NewDIDI GLOBAL INCsponsored ads$42,647,0003,016,060
+100.0%
0.44%
BZ NewKANZHUN LIMITEDsponsored ads$41,633,0001,050,000
+100.0%
0.43%
AKRO  AKERO THERAPEUTICS INC$41,102,000
-14.5%
1,656,6730.0%0.42%
-10.9%
KNSA  KINIKSA PHARMACEUTICALS LTD$40,676,000
-24.7%
2,920,0230.0%0.42%
-21.5%
XPEV BuyXPENG INCads$39,823,000
+65.6%
896,500
+36.1%
0.41%
+72.3%
LYEL NewLYELL IMMUNOPHARMA INC$38,147,0002,348,965
+100.0%
0.39%
HTHT  HUAZHU GROUP LTDsponsored ads$30,572,000
-3.8%
578,9020.0%0.32%
+0.3%
GDS SellGDS HLDGS LTDsponsored ads$30,611,000
-88.0%
390,000
-87.6%
0.32%
-87.5%
MLCO  MELCO RESORTS AND ENTMNT LTDadr$28,150,000
-16.8%
1,698,8770.0%0.29%
-13.2%
ROOT  ROOT INC$28,132,000
-15.0%
2,600,0000.0%0.29%
-11.3%
FMTX  FORMA THERAPEUTICS HLDGS INC$27,379,000
-11.2%
1,100,0000.0%0.28%
-7.5%
AAPL  APPLE INC$27,392,000
+12.1%
200,0000.0%0.28%
+17.0%
LEGN  LEGEND BIOTECH CORPsponsored ads$26,683,000
+41.5%
650,0000.0%0.28%
+47.8%
EM NewSMART SH GLOBAL LTDads$24,766,0004,080,000
+100.0%
0.26%
AXSM  AXSOME THERAPEUTICS INC$24,286,000
+19.1%
360,0000.0%0.25%
+24.4%
ACMR  ACM RESH INC$22,855,000
+26.5%
223,5850.0%0.24%
+31.3%
DYN  DYNE THERAPEUTICS INC$21,040,000
+35.5%
1,000,0000.0%0.22%
+41.8%
ALLO  ALLOGENE THERAPEUTICS INC$20,864,000
-26.1%
800,0000.0%0.22%
-22.9%
KDP SellKEURIG DR PEPPER$20,072,000
-39.2%
569,584
-40.7%
0.21%
-36.5%
IPSC NewCENTURY THERAPEUTICS INC$18,018,000614,095
+100.0%
0.18%
RGNX  REGENXBIO INC$17,716,000
+13.9%
456,0000.0%0.18%
+18.2%
MOGU  MOGU INCspon ads$17,342,000
-14.4%
10,446,9700.0%0.18%
-10.5%
OLMA  OLEMA PHARMACEUTICALS INC$17,359,000
-15.7%
620,3970.0%0.18%
-11.8%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$16,900,000
-26.9%
3,985,7970.0%0.17%
-23.7%
PRLD SellPRELUDE THERAPEUTICS INC$16,701,000
-38.5%
583,333
-6.9%
0.17%
-35.8%
SNOW  SNOWFLAKE INCcl a$15,233,000
+5.5%
63,0000.0%0.16%
+9.8%
SOHU  SOHU COM LTDsponsored ads$14,918,000
+18.3%
802,0340.0%0.15%
+23.2%
KURA  KURA ONCOLOGY INC$13,553,000
-26.2%
650,0000.0%0.14%
-23.1%
IGMS  IGM BIOSCIENCES INC$12,596,000
+8.5%
151,3900.0%0.13%
+13.0%
TALS NewTALARIS THERAPEUTICS INC$12,536,000853,344
+100.0%
0.13%
ADCT  ADC THERAPEUTICS SA$12,175,000
-0.2%
500,0000.0%0.12%
+3.3%
IMCR SellIMMUNOCORE HLDGS PLCads$10,846,000
-8.9%
277,754
-0.7%
0.11%
-5.1%
RNA  AVIDITY BIOSCIENCES INC$10,502,000
+13.3%
425,0000.0%0.11%
+17.4%
KRON SellKRONOS BIO INC$10,381,000
-46.1%
433,436
-34.2%
0.11%
-43.7%
PATH NewUIPATH INCcl a$10,190,000150,000
+100.0%
0.10%
MREO  MEREO BIOPHARMA GROUP PLCads$9,434,000
-5.9%
2,976,1210.0%0.10%
-2.0%
UXIN  UXIN LTDads$8,845,000
+229.1%
2,297,3180.0%0.09%
+237.0%
NKTX SellNKARTA INC$8,803,000
-25.6%
277,778
-22.7%
0.09%
-22.2%
COGT  COGENT BIOSCIENCES INC$8,110,000
-7.6%
1,000,0000.0%0.08%
-4.6%
CDAK  CODIAK BIOSCIENCES INC$6,795,000
+22.9%
366,7210.0%0.07%
+27.3%
LPTX  LEAP THERAPEUTICS INC$5,864,000
-13.7%
3,575,7450.0%0.06%
-10.4%
DSGN  DESIGN THERAPEUTICS INC$5,589,000
-33.5%
280,9910.0%0.06%
-30.1%
MAACU  MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025$5,340,000
+4.7%
500,0000.0%0.06%
+10.0%
NTES  NETEASE INCsponsored ads$5,013,000
+11.6%
43,5000.0%0.05%
+18.2%
RXDX  PROMETHEUS BIOSCIENCES INC$4,912,000
+34.5%
200,0000.0%0.05%
+41.7%
NewCYTOKINETICS INC$4,566,000230,718
+100.0%
0.05%
CJJD  CHINA JO-JO DRUGSTORES INC$4,556,000
-16.0%
4,840,0000.0%0.05%
-13.0%
CVET  COVETRUS INC$4,188,000
-9.9%
155,1240.0%0.04%
-6.5%
SFUN SellFANG HLDGS LTDadr new$3,883,000
-5.3%
327,720
-0.1%
0.04%
-2.4%
HOOK SellHOOKIPA PHARMA INC$2,467,000
-75.1%
269,368
-63.4%
0.02%
-74.5%
YSG  YATSEN HLDG LTDads$2,350,000
-24.1%
250,7640.0%0.02%
-22.6%
DGNRU  DRAGONEER GROWTH OPPORTUNITY COunit 08/18/2027$2,078,000
-0.1%
200,0000.0%0.02%0.0%
EDU  NEW ORIENTAL ED & TECHNOLOGYspon adr$645,000
-41.5%
78,7710.0%0.01%
-36.4%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$603,000
-7.8%
300,0000.0%0.01%0.0%
LEAPU  RIBBIT LEAP LTDunit 99/99/9999$556,000
+1.1%
50,0000.0%0.01%
+20.0%
TCRR ExitTCR2 THERAPEUTICS INC$0-39,577
-100.0%
-0.01%
MRUS ExitMERUS N V$0-46,532
-100.0%
-0.01%
RCUS ExitARCUS BIOSCIENCES INC$0-50,000
-100.0%
-0.01%
CYTK ExitCYTOKINETICS INC$0-230,718
-100.0%
-0.05%
NXTC ExitNEXTCURE INC$0-563,907
-100.0%
-0.06%
FDMT Exit4D MOLECULAR THERAPEUTICS IN$0-157,500
-100.0%
-0.07%
GMAB ExitGENMAB A/Ssponsored ads$0-265,529
-100.0%
-0.09%
PYPL ExitPAYPAL HLDGS INC$0-40,000
-100.0%
-0.10%
GRUB ExitGRUBHUB INC$0-169,386
-100.0%
-0.10%
CALT ExitCALLIDITAS THERAPEUTICS ABsponsered ads$0-944,716
-100.0%
-0.26%
CBPO ExitCHINA BIOLOGIC PRODS HLDGS I$0-2,962,076
-100.0%
-3.47%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings